Investigator

Ge Wang

Clark & Crossan Endowed Chair Professor · Rensselaer Polytechnic Institute, Biomedical Engineering

About

Research Interests

GWGe Wang
Papers(2)
Contrast-enhanced pho…Toosendanin reduces c…
Collaborators(1)
Margarida Barroso
Institutions(2)
Rensselaer Polytechni…Albany Medical College

Papers

Contrast-enhanced photon-counting micro-CT of tumor xenograft models

Abstract Objective . Photon-counting micro-computed tomography (micro-CT) is a major advance in small animal preclinical imaging. Small molecule- and nanoparticle-based contrast agents have been widely used to enable the differentiation of liver tumors from surrounding tissues using photon-counting micro-CT. However, there is a notable gap in the application of these market-available agents to the imaging of breast and ovarian tumors using photon-counting micro-CT. Herein, we have used photon-counting micro-CT to determine the effectiveness of these contrast agents in differentiating ovarian and breast tumor xenografts in live, intact mice. Approach . Nude mice carrying different types of breast and ovarian tumor xenografts (AU565, MDA-MB-231 and SKOV-3 human cancer cells) were injected with ISOVUE-370 (a small molecule-based agent) or Exitron Nano 12000 (a nanoparticle-based agent) and subjected to photon-counting micro-CT. To improve tumor visualization using photon-counting micro-CT, we developed a novel color visualization method, which changes color tones to highlight contrast media distribution, offering a robust alternative to traditional material decomposition methods with less computational demand. Main results . Our in vivo experiments confirm the effectiveness of this color visualization approach, showing distinct enhancement characteristics for each contrast agent. Qualitative and quantitative analyses suggest that Exitron Nano 12000 provides superior vasculature enhancement and better quantitative consistency across scans, while ISOVUE-370 delivers a more comprehensive tumor enhancement but with significant variance between scans due to its short blood half-time. Further, a paired t-test on mean and standard deviation values within tumor volumes showed significant differences between the AU565 and SKOV-3 tumor models with the nanoparticle-based contrast agent ( p -values < 0.02), attributable to their distinct vascularity, as confirmed by immunohistochemical analysis. Significance . These findings underscore the utility of photon-counting micro-CT in non-invasively assessing the morphology and anatomy of different tumor xenografts, which is crucial for tumor characterization and longitudinal monitoring of tumor progression and response to treatments.

Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway

Cisplatin (DDP) resistance is prevalent in ovarian cancer (OC) patients and contributes to the poor prognosis. Therefore, it is of great significance to develop new agent to intervene and even reverse DDP resistance in OC. Toosendanin (TSN), a triterpenoid extracted from the bark or fruits of Melia toosendan Sieb et Zucc, has been proved to possess significant antitumor activities. However, the efficacy of TSN on DDP resistance in OC has not been reported yet. The aim of this study is to investigate the effects of TSN on DDP resistance in OC and explore the molecular mechanism in vitro and in vivo. Human OC cell line (SKOV3) and DDP-resistant cell line (SKOV3/DDP) were used. Cell proliferation was measured by CCK-8 and colony formation assay. Annexin V/PI double staining and hoechst 33342 nuclear staining were employed to detect cell apoptosis. Transwell and wound-healing assay were used to determine the invasion and migration potential of cells respectively. Quantitative real-time PCR (qPCR) and western blotting were performed to detect the expression of molecules related to miR-195/ERK/β-catenin pathway. The effects and mechanism of TSN on DDP resistance of OC in vivo was investigated using xenograft model, TUNEL staining assay and immunohistochemistry. TSN improved the DDP sensitivity of SKOV3/DDP cells in vitro and in vivo, reflected in promoting inhibition of proliferation, invasion, migration and epithelial mesenchymal transformation (EMT) as well as induction of apoptosis by DDP. TSN could modulate the miR-195/ERK/β-catenin axis by upregulating the miR-195-5p expression and then suppressing ERK/GSK3β/β-catenin pathway which were activated in SKOV3/DDP cells. Moreover, co-treatment of β-catenin pathway activator LiCl or miR-195-5p silencing partially recovered the DDP resistance which was previously repressed by TSN. Both in vitro and in vivo data demonstrated that TSN could reduce DDP resistance in OC through regulating the miR-195/ERK/β-catenin pathway, highlighting the potential of TSN as an effective agent for favoring overcoming clinical DDP resistance in OC.

1227Works
2Papers
1Collaborators
Lung NeoplasmsCell Line, TumorBreast NeoplasmsOvarian NeoplasmsDiagnosis, Computer-AssistedCardiovascular Diseases

Positions

2013–

Clark & Crossan Endowed Chair Professor

Rensselaer Polytechnic Institute · Biomedical Engineering

2006–

Pritchard Professor

Virginia Tech · Biomedical Engineering (a joint department with Wake Forest Univ.)

2002–

Professor

University of Iowa · Radiology

1997–

Associate Prof.

University of Iowa · Radiology

1994–

Assistant Prof.

Washington University in Saint Louis School of Medicine · Mallinckrodt Inst. of Radiology

1992–

Instructor

Washington University in Saint Louis School of Medicine · Mallinckrodt Inst. of Radiology

Education

1992

PhD

University at Buffalo · Electrical & Computer Engineering

1991

MS

University at Buffalo · Electrical & Computer Engineering

1985

MS

Chinese Academy of Sciences · Institute of Remote Sensing Applications

1982

BE

Xidian University · Electrical Engineering

Keywords
X-ray tomographymulti-modality imagingartificial intelligencemachine learningdeep learning